UK markets close in 1 hour 21 minutes

Nektar Therapeutics (ITH.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
1.5210-0.0690 (-4.34%)
As of 08:03AM CEST. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

Currency in USD. All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
90,167
90,122
92,055
101,907
152,915
Cost of revenue
35,242
33,768
21,635
24,897
19,477
Gross profit
54,925
56,354
70,420
77,010
133,438
Operating expenses
Research development
111,101
114,162
218,323
400,269
408,678
Selling general and administrative
76,485
77,417
92,333
122,844
104,682
Total operating expenses
187,586
191,579
310,656
523,113
513,360
Operating income or loss
-132,661
-135,225
-240,236
-446,103
-379,922
Interest expense
24,460
25,334
28,911
47,313
37,118
Total other income/expenses net
-37,785
-134,706
-102,619
-32,595
-45,189
Income before tax
-176,012
-276,256
-364,983
-523,280
-443,947
Income tax expense
-172
-200
3,215
557
493
Income from continuing operations
-175,840
-276,056
-368,198
-523,837
-444,440
Net income
-175,840
-276,056
-368,198
-523,837
-444,440
Net income available to common shareholders
-175,840
-276,056
-368,198
-523,837
-444,440
Basic EPS
-1.55
-1.45
-1.97
-2.86
-2.49
Diluted EPS
-1.55
-1.45
-1.97
-2.86
-2.49
Basic average shares
189,301
190,001
187,138
183,298
178,581
Diluted average shares
189,301
190,001
187,138
183,298
178,581